BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Dec 1, 2016
Clinical News

Blisibimod: Ph III CHABLIS-SC1 data

BioCentury | Jul 25, 2016
Clinical News

Blisibimod: Interim Phase II data

BioCentury | Jun 22, 2015
Clinical News

Blisibimod: Completed Phase III enrollment

BioCentury | Mar 2, 2015
Clinical News

Blisibimod: Phase III ongoing

BioCentury | Oct 3, 2014
Clinical News

Lilly halts tabalumab for lupus

BioCentury | Jul 1, 2013
Clinical News

Blisibimod: Phase II started

BioCentury | Apr 1, 2013
Clinical News

Blisibimod: Phase III started

BioCentury | Dec 10, 2012
Clinical News

Blisibimod: Additional Phase IIb data

BioCentury | Jul 23, 2012
Clinical News

Blisibimod: Additional Phase IIb data

BioCentury | Jul 2, 2012
Clinical News

Blisibimod: Additional Phase IIb data

Items per page:
1 - 10 of 27